Keqing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keqing Li has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Lili Zhang
Hebei Provincial Mental Health Center, Baoding, China
3 shared publicationsYunshu Zhang
Hebei Provincial Mental Health Center
2 shared publicationsBin Yu
Mental Hosp Jiangxi Prov, Nanchang 330029, Jiangxi, Peoples R China
1 shared publicationBing Li
Hebei Provincial Mental Health Center, Baoding, People’s Republic of China
1 shared publicationBo Zhang
Sichuan Univ, Mental Hlth Ctr, W China Hosp, Chengdu 610041, Si Chuan, Peoples R China
1 shared publication- Chen Yao
Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China
1 shared publication
Latest Publications
- Open Access
- 3 July 2023
- Published by Springer Nature in Psychopharmacology
- Vol. 240 (8) , 1775-1787
Isoalantolactone relieves depression-like behaviors in mice after chronic social defeat stress via the gut-brain axis
Rationale: The management of depression continues to be challenging despite the variety of available antidepressants. Herbal medicines are used in many cultures but lack stringent testing to understand their efficacy and mechanism of action. Isoalantolactone (LAT) from Elecampane (Inula helenium) improved the chronic social defeat stress (CSDS)-induced anhedonia-like phenotype in mice comparable to fluoxetine, a selective serotonin reuptake inhibitor (SSRI). Objectives: Compare the effects of LAT and fluoxetine on depression-like behaviors in mice exposed to CSDS. Result: The CSDS-induced decrease in protein expression of postsynaptic density (PSD95), brain derived neurotrophic factor (BDNF), and glutamate receptor subunit-1 (GluA1) in the prefrontal cortex was restored by LAT. LAT showed robust anti-inflammatory activity and can lessen the increase in IL-6 and TNF-α caused by CSDS. CSDS altered the gut microbiota at the taxonomic level, resulting in significant changes in α- and β-diversity. LAT treatment reestablished the bacterial abundance and diversity and increased the production of butyric acid in the gut that was inhibited by CSDS. The levels of butyric acid were negatively correlated with the abundance of Bacteroidetes, and positively correlated with those of Proteobacteria and Firmicutes across all treatment groups. Conclusions: The current data suggest that, similar to fluoxetine, LAT show antidepressant-like effects in mice exposed to CSDS through the modulation of the gut-brain axis.
- 3 July 2023
- Published by Springer Nature in Psychopharmacology
- Vol. 240 (8) , 1775-1787
Open AccessIsoalantolactone relieves depression-like behaviors in mice after chronic social defeat stress via the gut-brain axis
Rationale: The management of depression continues to be challenging despite the variety of available antidepressants. Herbal medicines are used in many cultures but lack stringent testing to understand their efficacy and mechanism of action. Isoalantolactone (LAT) from Elecampane (Inula helenium) improved the chronic social defeat stress (CSDS)-induced anhedonia-like phenotype in mice comparable to fluoxetine, a selective serotonin reuptake inhibitor (SSRI). Objectives: Compare the effects of LAT and fluoxetine on depression-like behaviors in mice exposed to CSDS. Result: The CSDS-induced decrease in protein expression of postsynaptic density (PSD95), brain derived neurotrophic factor (BDNF), and glutamate receptor subunit-1 (GluA1) in the prefrontal cortex was restored by LAT. LAT showed robust anti-inflammatory activity and can lessen the increase in IL-6 and TNF-α caused by CSDS. CSDS altered the gut microbiota at the taxonomic level, resulting in significant changes in α- and β-diversity. LAT treatment reestablished the bacterial abundance and diversity and increased the production of butyric acid in the gut that was inhibited by CSDS. The levels of butyric acid were negatively correlated with the abundance of Bacteroidetes, and positively correlated with those of Proteobacteria and Firmicutes across all treatment groups. Conclusions: The current data suggest that, similar to fluoxetine, LAT show antidepressant-like effects in mice exposed to CSDS through the modulation of the gut-brain axis.
- Open Access
- 29 November 2022
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 18, 2783-2794
Depression and Cognitive Impairment: Current Understanding of Its Neurobiology and Diagnosis
Background: Eye movement is critical for obtaining precise visual information and providing sensorimotor processes and advanced cognitive functions to the brain behavioral indicator. Methods: In this article, we present a narrative review of the eye-movement paradigms (such as fixation, smooth pursuit eye movements, and memory-guided saccade tasks) in major depression. Results: Characteristics of eye movement are considered to reflect several aspects of cognitive deficits regarded as an aid to diagnosis. Findings regarding depressive disorders showed differences from the healthy population in paradigms, the characteristics of eye movement may reflect cognitive deficits in depression. Neuroimaging studies have demonstrated the effectiveness of different eye movement paradigms for MDD screening. Conclusion: Depression can be distinguished from other mental illnesses based on eye movements. Eye movement reflects cognitive deficits that can help diagnose depression, and it can make the entire diagnostic process more accurate.
- 29 November 2022
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 18, 2783-2794
Open AccessDepression and Cognitive Impairment: Current Understanding of Its Neurobiology and Diagnosis
Background: Eye movement is critical for obtaining precise visual information and providing sensorimotor processes and advanced cognitive functions to the brain behavioral indicator. Methods: In this article, we present a narrative review of the eye-movement paradigms (such as fixation, smooth pursuit eye movements, and memory-guided saccade tasks) in major depression. Results: Characteristics of eye movement are considered to reflect several aspects of cognitive deficits regarded as an aid to diagnosis. Findings regarding depressive disorders showed differences from the healthy population in paradigms, the characteristics of eye movement may reflect cognitive deficits in depression. Neuroimaging studies have demonstrated the effectiveness of different eye movement paradigms for MDD screening. Conclusion: Depression can be distinguished from other mental illnesses based on eye movements. Eye movement reflects cognitive deficits that can help diagnose depression, and it can make the entire diagnostic process more accurate.
- Open Access
- 14 October 2021
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 9
Lifetime and 1-Month Prevalence of Mental Disorders in Hebei Province, China: A Community-Based Cross-Sectional Study
Background: The prevalence of mental disorders is an important topic, which has been reported in different countries in the world. In China, some studies were also conducted to get the prevalence of mental disorders at the national level and in some metropolitan cities. However, the prevalence of mental disorders in Chinese underdeveloped provinces has not been reported internationally in recent decades. Due to the discrepancy in the social-economic development of different Chinese provinces, we also have reasons to believe the different prevalence of mental disorders between underdeveloped provinces and other provinces.Method: A community-based cross-sectional study was conducted among community residents aged 18 years and older in Hebei province, China. We screened 20,884 community residents in this study, and a Structured Clinical Interview for Diagnostic and Statistical Manual (DSM-IV) Axis I disorders was used to make the diagnoses of mental disorders.Results: The weighted lifetime prevalence of mental disorders was 15.87% (95% CI 15.38–16.38%), and the 1-month prevalence was 10.79% (95% CI 10.37–11.22%). Anxiety disorder ranked first in the classification of mental disorders for both lifetime (6.56%) and 1-month prevalence (6.25%). The weighted lifetime and 1-month region–gender–age-specific prevalence of mental disorders was also analyzed in this study.Conclusions: Mental disorders have been an important issue in Chinese economically underdeveloped regions, and the prevalence was at a high level compared with the results in the 2000s. There are several serious challenges in the work of Chinese mental disorders, which should be paid more attention to.
- 14 October 2021
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 9
Open AccessLifetime and 1-Month Prevalence of Mental Disorders in Hebei Province, China: A Community-Based Cross-Sectional Study
Background: The prevalence of mental disorders is an important topic, which has been reported in different countries in the world. In China, some studies were also conducted to get the prevalence of mental disorders at the national level and in some metropolitan cities. However, the prevalence of mental disorders in Chinese underdeveloped provinces has not been reported internationally in recent decades. Due to the discrepancy in the social-economic development of different Chinese provinces, we also have reasons to believe the different prevalence of mental disorders between underdeveloped provinces and other provinces.Method: A community-based cross-sectional study was conducted among community residents aged 18 years and older in Hebei province, China. We screened 20,884 community residents in this study, and a Structured Clinical Interview for Diagnostic and Statistical Manual (DSM-IV) Axis I disorders was used to make the diagnoses of mental disorders.Results: The weighted lifetime prevalence of mental disorders was 15.87% (95% CI 15.38–16.38%), and the 1-month prevalence was 10.79% (95% CI 10.37–11.22%). Anxiety disorder ranked first in the classification of mental disorders for both lifetime (6.56%) and 1-month prevalence (6.25%). The weighted lifetime and 1-month region–gender–age-specific prevalence of mental disorders was also analyzed in this study.Conclusions: Mental disorders have been an important issue in Chinese economically underdeveloped regions, and the prevalence was at a high level compared with the results in the 2000s. There are several serious challenges in the work of Chinese mental disorders, which should be paid more attention to.
- Open Access
- 9 January 2018
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 11, 260
Olanzapine Reverses MK-801-Induced Cognitive Deficits and Region-Specific Alterations of NMDA Receptor Subunits
Cognitive dysfunction constitutes an essential component in schizophrenia for its early presence in the pathophysiology of the disease and close relatedness to life quality of patients. To develop effective treatment of cognitive deficits, it is important to understand their neurobiological causes and to identify potential therapeutic targets. In this study, adopting repeated MK-801 treatment as an animal model of schizophrenia, we investigated whether antipsychotic drugs, olanzapine and haloperidol, can reverse MK-801-induced cognitive deficits and how the reversal processes recruited proteins involved in glutamate neurotransmission in rat medial prefrontal cortex (mPFC) and hippocampus. We found that low-dose chronic MK-801 treatment impaired object-in-context recognition memory and reversal learning in the Morris water maze, leaving reference memory relatively unaffected, and that these cognitive deficits can be partially reversed by olanzapine, not haloperidol, treatment. At the molecular level, chronic MK-801 treatment resulted in the reduction of multiple N-methyl-D-aspartate (NMDA) receptor subunits in rat mPFC and olanzapine, not haloperidol, treatment restored the levels of GluN1 and phosphorylated GluN2B in this region. Taken together, MK-801-induced cognitive deficits may be associated with region-specific changes in NMDA receptor subunits and the reversal of specific NMDA receptor subunits may underlie the cognition-enhancing effects of olanzapine.
- 9 January 2018
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 11, 260
Open AccessOlanzapine Reverses MK-801-Induced Cognitive Deficits and Region-Specific Alterations of NMDA Receptor Subunits
Cognitive dysfunction constitutes an essential component in schizophrenia for its early presence in the pathophysiology of the disease and close relatedness to life quality of patients. To develop effective treatment of cognitive deficits, it is important to understand their neurobiological causes and to identify potential therapeutic targets. In this study, adopting repeated MK-801 treatment as an animal model of schizophrenia, we investigated whether antipsychotic drugs, olanzapine and haloperidol, can reverse MK-801-induced cognitive deficits and how the reversal processes recruited proteins involved in glutamate neurotransmission in rat medial prefrontal cortex (mPFC) and hippocampus. We found that low-dose chronic MK-801 treatment impaired object-in-context recognition memory and reversal learning in the Morris water maze, leaving reference memory relatively unaffected, and that these cognitive deficits can be partially reversed by olanzapine, not haloperidol, treatment. At the molecular level, chronic MK-801 treatment resulted in the reduction of multiple N-methyl-D-aspartate (NMDA) receptor subunits in rat mPFC and olanzapine, not haloperidol, treatment restored the levels of GluN1 and phosphorylated GluN2B in this region. Taken together, MK-801-induced cognitive deficits may be associated with region-specific changes in NMDA receptor subunits and the reversal of specific NMDA receptor subunits may underlie the cognition-enhancing effects of olanzapine.
- Open Access
- 1 July 2016
- Published by Universe Scientific Publishing Pte. Ltd. in Journal of Nursing
- Vol. 5 (1) , 8-12
Repetitive Transcranial Magnetic Stimulation Treatment Adherence and the Research Progress of Nursing Intervention in the Patients with Mental Disorders of China
By reviewing literatures, the author summarized the influence factors of compliance in rTMS treatment. The major factors were found to be involved patient factors, medical factors, associated-therapeutic factors and social supporting factors and put forward corresponding nursing intervention measures, in order to improve the patients' compliance, satisfaction and the treatment effect.
- 1 July 2016
- Published by Universe Scientific Publishing Pte. Ltd. in Journal of Nursing
- Vol. 5 (1) , 8-12
Open AccessRepetitive Transcranial Magnetic Stimulation Treatment Adherence and the Research Progress of Nursing Intervention in the Patients with Mental Disorders of China
By reviewing literatures, the author summarized the influence factors of compliance in rTMS treatment. The major factors were found to be involved patient factors, medical factors, associated-therapeutic factors and social supporting factors and put forward corresponding nursing intervention measures, in order to improve the patients' compliance, satisfaction and the treatment effect.
- Open Access
- 1 October 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 69, 102-109
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial
- 1 October 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 69, 102-109
Open AccessComparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial
- 13 December 2012
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 14 (6)
A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders
To investigate the sleep characteristics of a community sample of patients with 13 types of mental disorders. Subjects aged 18 years and older were sampled from the Epidemiologic Sites Survey of Mental Illness at a mental health center in Hebei Province, Baoding, China, from October 2004 to March 2005. The study group included 1,874 subjects who met the diagnostic criteria of 13 types of mental disorders according to the Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (major depressive disorder, panic disorder, generalized anxiety disorder, posttraumatic stress disorder, dysthymic disorder, bipolar affective disorder, somatoform disorder, obsessive-compulsive disorder, specific phobia, schizophrenia, adjustment disorder, social phobia, and alcohol abuse and dependence.) The control group included 15,117 subjects without mental disorders. The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality, and the Global Assessment of Functioning (GAF) was used to assess social life function. The prevalence of sleep disorders was 11.6% in the survey respondents. The prevalence of sleep disturbances in the group with 13 types of mental disorders ranged from 19.30% to 69.92%. There was a significant difference in the prevalence of sleep disorders between the study group (48.61%) and the control group (5.55%; P < .01). The prevalence of sleep disturbance in subjects with major depressive disorder and generalized anxiety disorder was 69.92% and 58.27%, respectively. Longer sleep latency and shorter sleep duration were the most common features of low quality sleep in patients with mental disorders. There was a significant difference in sleep latency and duration in subjects with major depressive disorder (P < .01), dysthymic disorder (P < .01), and generalized anxiety disorder (P < .01) compared to control subjects. Sleep medication was used most by subjects with schizophrenia and least by those with social phobia. Daytime dysfunction was most notable in subjects with major depressive disorder. Subjects with mental disorders with sleep disorders tended to be older than those with mental disorders without sleep disorders. The prevalence of sleep disorders was higher in patients with mental disorders who were female, older, less educated, retired or farmers, and widowed. There was no relation between the severity of depression and sleep disorders. The prevalence of sleep disorders in subjects with mental disorders was high. Longer sleep latency and shorter sleep duration were the most common characteristics of low quality sleep in the patients with mental disorders and were most notable in those with depression.
- 13 December 2012
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 14 (6)
A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders
To investigate the sleep characteristics of a community sample of patients with 13 types of mental disorders. Subjects aged 18 years and older were sampled from the Epidemiologic Sites Survey of Mental Illness at a mental health center in Hebei Province, Baoding, China, from October 2004 to March 2005. The study group included 1,874 subjects who met the diagnostic criteria of 13 types of mental disorders according to the Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (major depressive disorder, panic disorder, generalized anxiety disorder, posttraumatic stress disorder, dysthymic disorder, bipolar affective disorder, somatoform disorder, obsessive-compulsive disorder, specific phobia, schizophrenia, adjustment disorder, social phobia, and alcohol abuse and dependence.) The control group included 15,117 subjects without mental disorders. The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality, and the Global Assessment of Functioning (GAF) was used to assess social life function. The prevalence of sleep disorders was 11.6% in the survey respondents. The prevalence of sleep disturbances in the group with 13 types of mental disorders ranged from 19.30% to 69.92%. There was a significant difference in the prevalence of sleep disorders between the study group (48.61%) and the control group (5.55%; P < .01). The prevalence of sleep disturbance in subjects with major depressive disorder and generalized anxiety disorder was 69.92% and 58.27%, respectively. Longer sleep latency and shorter sleep duration were the most common features of low quality sleep in patients with mental disorders. There was a significant difference in sleep latency and duration in subjects with major depressive disorder (P < .01), dysthymic disorder (P < .01), and generalized anxiety disorder (P < .01) compared to control subjects. Sleep medication was used most by subjects with schizophrenia and least by those with social phobia. Daytime dysfunction was most notable in subjects with major depressive disorder. Subjects with mental disorders with sleep disorders tended to be older than those with mental disorders without sleep disorders. The prevalence of sleep disorders was higher in patients with mental disorders who were female, older, less educated, retired or farmers, and widowed. There was no relation between the severity of depression and sleep disorders. The prevalence of sleep disorders in subjects with mental disorders was high. Longer sleep latency and shorter sleep duration were the most common characteristics of low quality sleep in the patients with mental disorders and were most notable in those with depression.
- Open Access
- 1 December 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 135 (1-3) , 106-110
A comparison of the clinical characteristics of Chinese patients with recurrent major depressive disorder with and without dysthymia
- 1 December 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 135 (1-3) , 106-110
Open AccessA comparison of the clinical characteristics of Chinese patients with recurrent major depressive disorder with and without dysthymia